These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 17893283)

  • 41. Guidelines for hormone treatment of women in the menopausal transition and beyond.
    Naftolin F; Schneider HP; Sturdee DW;
    Maturitas; 2005 May; 51(1):15-20. PubMed ID: 15883104
    [No Abstract]   [Full Text] [Related]  

  • 42. An update on new orally administered contraceptives for women.
    Nelson AL
    Expert Opin Pharmacother; 2015; 16(18):2759-72. PubMed ID: 26512437
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hormone therapy and risk of venous thromboembolism among postmenopausal women.
    Canonico M; Scarabin PY
    Climacteric; 2009; 12 Suppl 1():76-80. PubMed ID: 19811247
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Hormone replacement therapy in postmenopausal women: all the treatments are not the same].
    Ribot C; Trémollieres F
    Gynecol Obstet Fertil; 2007 May; 35(5):388-97. PubMed ID: 17392010
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Bias from depletion of susceptibles: the example of hormone replacement therapy and the risk of venous thromboembolism.
    Renoux C; Dell'Aniello S; Brenner B; Suissa S
    Pharmacoepidemiol Drug Saf; 2017 May; 26(5):554-560. PubMed ID: 28326633
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hormones and venous thromboembolism among postmenopausal women.
    Scarabin PY
    Climacteric; 2014 Dec; 17 Suppl 2():34-7. PubMed ID: 25223916
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Postmenopausal estrogen replacement therapy and risk of developing systemic lupus erythematosus or discoid lupus.
    Petri M
    J Rheumatol; 1999 Mar; 26(3):752. PubMed ID: 10090197
    [No Abstract]   [Full Text] [Related]  

  • 48. Hormones and pregnancy: thromboembolic risks for women.
    Kujovich JL
    Br J Haematol; 2004 Aug; 126(4):443-54. PubMed ID: 15287937
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Postmenopausal hormone therapy and cardiovascular disease: an overview of main findings.
    Canonico M; Straczek C; Oger E; Plu-Bureau G; Scarabin PY
    Maturitas; 2006 Jul; 54(4):372-9. PubMed ID: 16730142
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Renewing the recognition on benefit and risk of long-term hormone replacement therapy in postmenopausal women].
    Zhang YW
    Zhonghua Fu Chan Ke Za Zhi; 2003 Aug; 38(8):487-8. PubMed ID: 14627037
    [No Abstract]   [Full Text] [Related]  

  • 51. [The SBU revises its view on estrogen replacement therapy in climacteric. Evidently increased risk of thrombosis and breast cancer].
    Hovelius B
    Lakartidningen; 2002 Jul; 99(28-29):3014-5. PubMed ID: 12170508
    [No Abstract]   [Full Text] [Related]  

  • 52. Further evidence for promoting transdermal estrogens in the management of postmenopausal symptoms.
    Canonico M; Scarabin PY
    Menopause; 2011 Oct; 18(10):1038-9. PubMed ID: 21946050
    [No Abstract]   [Full Text] [Related]  

  • 53. Venous thrombosis is not increased in younger women on genuine oestrogen postmenopausal hormonal replacement therapy: results from the Danish Osteoporosis Prevention Study (DOPS).
    Kristensen SR; Abrahamsen B; Madsen JS; Gram J; Rejnmark L; Rud B; Jespersen J
    Thromb Haemost; 2006 May; 95(5):915-6. PubMed ID: 16676096
    [No Abstract]   [Full Text] [Related]  

  • 54. [Postmenopausal hormone replacement therapy and cardiovascular disease].
    Høibraaten E
    Tidsskr Nor Laegeforen; 2002 Jun; 122(16):1564-5. PubMed ID: 12119783
    [No Abstract]   [Full Text] [Related]  

  • 55. A modern approach to postmenopausal HRT: trading bleeding with safety.
    Al-Azzawi F; Wahab M
    Womens Health (Lond); 2012 Jan; 8(1):1-4. PubMed ID: 22171766
    [No Abstract]   [Full Text] [Related]  

  • 56. [Risk of thromboembolism in contraception and hormone substitution: an update and recommendations].
    van den Brûle F; Gaspard U
    J Pharm Belg; 2004; 59(1):38-40. PubMed ID: 15129579
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Exogenous sex hormones and thrombophilia.
    Walker ID
    Obstet Gynecol Clin North Am; 2006 Sep; 33(3):467-79, x. PubMed ID: 16962922
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Patch instead of pill: a safer menopausal estrogen?
    Cushman M
    Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):136-7. PubMed ID: 20089948
    [No Abstract]   [Full Text] [Related]  

  • 59. Estrogen plus progestin, benefits and risks: the "Women's Health Initiative" trials.
    Keller KB; Lemberg L
    Am J Crit Care; 2005 Mar; 14(2):157-60. PubMed ID: 15728959
    [No Abstract]   [Full Text] [Related]  

  • 60. Hormone replacement therapy and thrombotic risk: beauty is only skin deep.
    Rosendaal FR
    Nat Clin Pract Cardiovasc Med; 2008 Nov; 5(11):684-5. PubMed ID: 18797429
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.